3.120USD+1.96%Mkt Cap: 1.06B $P/E: 52.001d ago
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price…
Industry Peers
Health Information Services$32.06BUSDP/E 35.0
$13.38BUSDP/E 88.5
$9.62BUSD
$8.27BUSDP/E 37.0
$6.65BUSD
$5.65BUSD
$4.44BUSDP/E 34.6
$3.43BUSDP/E 160.1
$2.24BUSD
$2.14BUSDP/E 106.8
$1.71BUSD
$1.41BUSD
$1.17BUSD
$1.13BUSD
$874.42MUSDP/E Infinity
$845.49MUSDP/E 43.2
$672.72MUSDP/E 68.1
$637.77MUSD
$581.77MUSDP/E 27.4
$584.81MUSD
$552.27MUSDP/E 13.1
$524.39MUSD
$516.62MUSD
$494.46MUSDP/E 56.3
$460.71MUSDP/E 25.8
$446.52MUSDP/E 25.4
$393.58MUSDP/E 90.5
$368.70MUSDP/E 45.6
$321.33MUSD
$230.81MUSDP/E 14.1
$224.12MUSDP/E 18.2
$217.63MUSD
$182.96MUSD
$156.35MUSDP/E 39.4
$168.48MUSD
$148.67MUSDP/E 29.6
$123.72MUSDP/E Infinity
$124.79MUSDP/E 18.5
$113.48MUSDP/E 25.4
$99.01MUSDP/E 17.9
$86.66MUSD
$65.63MUSDP/E 11.3
$62.29MUSDP/E 22.6
$57.34MUSD
$47.87MUSDP/E 57.6
$49.50MUSD
$40.55MUSDP/E 38.7
$39.14MUSD
$31.93MUSD
$26.93MUSDP/E 26.0
$22.91MUSDP/E 54.8
$20.17MUSD
$18.43MUSD
$12.99MUSD
$13.69MUSD
$12.35MUSD
$11.72MUSD
$9.78MUSDP/E 15.1
$6.67MUSD
$6.50MUSD
$5.63MUSD
$4.88MUSD
$3.78MUSDP/E Infinity
$3.83MUSDP/E 0.0
$3.40MUSD
$2.98MUSD
$2.70MUSD
$2.16MUSDP/E Infinity
$693.4KUSD
$548.9KUSDP/E 0.0
$282.6KUSD
—
CRY
GraniteShares YieldBOOST CRCL ETF—
EYES
Corgi Data & Surveillance ETF—P/E 30.8
—
—
Indicators:|
Key Statistics
Company
Market Cap1.06B $
Enterprise Value1.34B $
Revenue (TTM)787.89M $
Gross Profit739.26M $
Net Income (TTM)30.44M $
Revenue/Share2.273 USD
Last Price3.120 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees697
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)52.00
P/E (Forward)8.71
PEG—
EV/EBITDA12.27
EV/Revenue1.70
P/S1.34
P/B1.69
EPS (TTM)0.06
EPS (Forward)0.36
52W Range
1.77033% of range5.810
52W High5.810 USD
52W Low1.770 USD
Profitability
Gross Margin92.77%
Oper. Margin7.22%
EBITDA Margin13.89%
Profit Margin3.82%
ROE4.94%
ROA2.17%
Growth
Revenue Growth-4.40%
Earnings Growth-88.30%
Cash Flow & Leverage
Operating CF167.90M $
CapEx (TTM)74.02M $
FCF Margin10.74%
FCF Yield8.01%
Net Debt305.64M $
Net Debt/EBITDA2.79
Balance Sheet
Debt/Equity0.88
Current Ratio1.47
Quick Ratio0.56
Book Value/Sh1.843 USD
Cash/Share0.6960 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)3.181 USD
Upside (mean)+1.9%
Target Range2.250 USD – 4.000 USD
$2.250+1.9% to mean$4.000
# Analysts13
Ownership
Shares Out.104.71M
Float91.73M
Insiders12.78%
Institutions56.17%
Short Interest
Short Ratio5.1d
Short % Float7.18%
Short % Out.1.98%
Shares Short6.70M
Short (prev mo.)7.22M
Technical
SMA 502.766 (+12.8%)
SMA 2002.768 (+12.7%)
Beta1.61
S&P 52W Chg20.25%
Avg Vol (30d)1.13M
Avg Vol (10d)972.31K
Technical Indicators
RSI (14)64.3
MACD0.1022
MACD Signal0.0880
MACD Hist.+0.0141
BB Upper3.235 USD
BB Middle2.878 USD
BB Lower2.521 USD
BB Width24.83%
ATR (14)0.1358 USD
Vol Ratio (20d)1.01x